SOURCE: Atossa Genetics Inc.

Atossa Genetics Inc.

January 06, 2015 08:00 ET

Atossa Genetics to Present at Upcoming Investor Conferences in January 2015

SEATTLE, WA--(Marketwired - Jan 6, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that management will present at the 8th Annual OneMedForum 2015 on Tuesday, January 13th, 2015 at 9:30 am PST at the Marriott Marquis Hotel in San Francisco, CA. Management will also present at the Biotech Showcase 2015 on Tuesday, January 13 at 3:00 pm PST in the Mission I Room at the Parc 55 Wyndham San Francisco, Union Square in San Francisco, CA. The company will be available for investor meetings January 12 through January 15, 2015.

About Atossa Genetics

Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The laboratory services and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For additional information, please visit www.atossagenetics.com.

Forward-Looking Statements

Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory clearances needed by Atossa to sell its products, responses to regulatory matters, Atossa's ability to continue to manufacture and sell its products, recalls of products, the efficacy of Atossa's products and services, performance of distributors, estimated future expenses and cash needs, whether Atossa can launch in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline in a timely and cost effective manner, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.